Apollomics
NASDAQ: APLMFoster City, US · 1 known investors
Biotech
Founders & leadership
H(
Hung-Wen (Howard) ChenNamed on SEC filing
HY
Hung-Hsien YenNamed on SEC filing
Y(
Yi-Kuei (Alex) ChenNamed on SEC filing
H(
Hong-Jung (Moses) ChenNamed on SEC filing
H(
Hsien-Shu (Jerry) TsaiNamed on SEC filing
Y(
Ya-Chi (Claudia) HuangNamed on SEC filing
PL
Peter LinNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$10M disclosed across 1 round · 2026
▶$10MraisedAug 2026 · 8 investors · BiotechnologyRule 506(b)
▶$10MraisedAug 2026 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Hung-Wen (Howard) ChenExecutive Officer, Director
- Hung-Hsien YenDirector
- Yi-Kuei (Alex) ChenExecutive Officer, Director
- Hong-Jung (Moses) ChenDirector
- Hsien-Shu (Jerry) TsaiDirector
- Ya-Chi (Claudia) HuangDirector
- Peter LinExecutive Officer
- Offering amount
- $10M
- Amount sold
- $10M
- Minimum investment
- $100K
- First sale
- Aug 2026
- Incorporated
- Corporation, Cayman Islands
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Apollomics's investors?
- Apollomics's investors include Maxpro Ventures.
- How much funding has Apollomics raised?
- Apollomics has disclosed $10M raised across 1 round.
- Where is Apollomics headquartered?
- Apollomics is headquartered in Foster City, US.